Insights

Early stage focus Oncopeptides is a small-to-mid-sized biotech focused on therapies for difficult-to-treat hematological diseases with revenue under $1M, indicating a potential demand for early-stage clinical collaboration, research partnerships, and pilot programs.

US footprint With a U.S. headquarters in Waltham and offices in Los Altos, Oncopeptides maintains a strategic presence in major biotech hubs, presenting opportunities for regional partnerships, contract development, and access to the Boston and San Francisco ecosystems.

Hematology focus Specialization in hematological cancers suggests sales opportunities with hematology-oncology diagnostic and therapeutic vendors, CROs, and clinical trial services that target blood cancers and related disorders.

Tech readiness A modern tech stack including Azure, Shopify, WordPress, and JSON-LD indicates digital commerce and cloud capabilities that could support technology partnerships, digital marketing collaborations, and data-driven sales enablement.

Global partnerships Headquartered in Sweden with a U.S. presence and a globally oriented mission implies openness to strategic collaborations, licensing, and co-development deals with large pharma or specialty biotech players seeking hematology assets.

Similar companies to Oncopeptides, Inc. (U.S.)

Oncopeptides, Inc. (U.S.) Tech Stack

Oncopeptides, Inc. (U.S.) uses 8 technology products and services including Open Graph, WordPress, Cookiebot, and more. Explore Oncopeptides, Inc. (U.S.)'s tech stack below.

  • Open Graph
    Content Management System
  • Content Management System
  • Cookie Compliance
  • E-commerce
  • JSON-LD
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • PWA
    Miscellaneous
  • Platform As A Service

Oncopeptides, Inc. (U.S.)'s Email Address Formats

Oncopeptides, Inc. (U.S.) uses at least 6 email formats:
Oncopeptides, Inc. (U.S.) Email FormatsExamplePercentage
First.Last@oncopeptides.comJohn.Doe@oncopeptides.com
91%
FirstLast@oncopeptides.comJohnDoe@oncopeptides.com
5%
First.Middle.Last@oncopeptides.comJohn.Michael.Doe@oncopeptides.com
3%
LastF@oncopeptides.comDoeJ@oncopeptides.com
1%
First-Last@oncopeptides-us.comJohn-Doe@oncopeptides-us.com
67%
LastF@oncopeptides-us.comDoeJ@oncopeptides-us.com
33%

Frequently Asked Questions

What is Oncopeptides, Inc. (U.S.)'s official website and social media links?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s official website is oncopeptides-us.com and has social profiles on LinkedIn.

How much revenue does Oncopeptides, Inc. (U.S.) generate?

Minus sign iconPlus sign icon
As of August 2026, Oncopeptides, Inc. (U.S.)'s annual revenue is estimated to be <$1M.

What is Oncopeptides, Inc. (U.S.)'s NAICS code?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Oncopeptides, Inc. (U.S.) have currently?

Minus sign iconPlus sign icon
As of August 2026, Oncopeptides, Inc. (U.S.) has approximately 201 employees across 1 continents, including North America. Key team members include Head Of Research: F. L., Head Of Us Human Resources: M. F. and Executive Director, Medical Affairs: E. M. Explore Oncopeptides, Inc. (U.S.)'s employee directory with LeadIQ.

What industry does Oncopeptides, Inc. (U.S.) belong to?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.) operates in the Pharmaceuticals industry.

What technology does Oncopeptides, Inc. (U.S.) use?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s tech stack includes Open Graph, WordPress, Cookiebot, Shopify, JSON-LD, jQuery, PWA and Microsoft Azure.

What is Oncopeptides, Inc. (U.S.)'s email format?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s email format typically follows the pattern of First.Last@oncopeptides.com. Find more Oncopeptides, Inc. (U.S.) email formats with LeadIQ.

When was Oncopeptides, Inc. (U.S.) founded?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.) was founded in 2000.
Oncopeptides, Inc. (U.S.) logo

Oncopeptides, Inc. (U.S.)

PharmaceuticalsMassachusetts, United States201-500 Employees

Oncopeptides, Inc. operates within the pharmaceutical manufacturing sector, focusing on developing therapies for difficult-to-treat hematological diseases. The company aims to provide treatment options driven by scientific research and innovation, with a mission that centers on offering new possibilities to patients, caregivers, and healthcare providers dealing with cancer. Its U.S. presence is headquartered in Waltham, Massachusetts, with additional footprint in California, and its global headquarters are in Stockholm, Sweden, reflecting a bi-national orientation and a broader development platform.

Positioned in the specialty biopharma space, Oncopeptides concentrates on addressing unmet clinical needs in hematology. The organization serves a medical and professional audience that seeks advanced treatment options for challenging blood cancers, operating from multiple U.S. locations to support its activities in a major biotechnology corridor. The information indicates a formal corporate footprint in the Boston-area region to facilitate its U.S. operations and research collaborations.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2000
Employees
201-500

Section iconFunding & Financials

  • <$1M

    Oncopeptides, Inc. (U.S.)'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.